Abstracts

1008 – Treatment Removes Lesions, Not Virus: A Decade of HPV Persistence in Women Living With HIV

Background While ablative and excisional methods aim to remove cervical intraepithelial neoplasia (CIN) in women living with HIV (WLH), its effects on long-term clearance of HPV infection is unclear. HPV persistence remains a key driver of CIN recurrence, yet post-treatment HPV dynamics are poorly characterized. Understanding these dynamics is essential if HPV detection is to…

1010 – Baseline CD4 Count Influences HPV Vaccine Response in PWH: Two-Year Follow-Up

Background Data on HPV-specific T-cell responses to the nonavalent Gardasil 9® vaccine in people with HIV(PWH) are limited. Given the critical role of cellular mediated-immunity(CMI) in vaccine efficacy, we evaluated post-vaccination T-cell responses in virally suppressed PWH on ART, stratified by CD4 T-cell count at time of first vaccine dose. Methods We prospectively enrolled PWH…

315 – CD4 Counts Shape Humoral Responses to the Recombinant Zoster Vaccine in People With HIV (PWH)

Background The adjuvanted recombinant zoster vaccine (RZV), based on varicella glycoprotein E (gE) and licensed in 2017, prevents herpes zoster (HZ) and induces durable humoral responses in people without HIV (typically >10 years). The incidence of HZ is higher among PWH, yet data on vaccine response and durability remain limited. We evaluated humoral immune responses…

326 – HIV Reservoir Size Relates to Comorbidities in People With HIV on Long-Term Antiretroviral Therapy

Background Although antiretroviral therapy (ART) effectively suppresses viral replication, HIV-1 persists as integrated proviral HIV-1 DNA within long-lived cells. This integrated HIV-1 DNA does not only underly the risk of viral rebound but also serves as the source of viral RNA transcription, even during suppressive ART. Most of these transcripts are abortive and do not…

1079 – Sentiment Analysis of WhatsApp Messages to Identify Unrecognized HIV Prevention Needs in Kenya

Background Identifying HIV prevention needs is challenging. Common approaches (e.g., public health campaigns, HIV risk scores) have limited sensitivity. Sentiment analysis uses natural language processing, text analysis, and computational linguistics to identify and study affective states and subjective information. This study explored a novel use of sentiment analysis with WhatsApp messages to identify unrecognized HIV…

917 – Safety-Net Strain Ahead: High Uninsurance Among Patients With Advanced HIV at a Ryan White Clinic

Background Insurance coverage is a critical determinant of access to HIV care, and lack of access to care can lead to late presentation and progression to advanced HIV disease. Understanding the relationship between insurance status and hospital utilization of patients with advanced HIV is important as recent policy changes are expected to increase uninsurance and…

378 – Placenta as a Model to Study Immune Dysfunction and HIV-1 Reservoirs in Macrophages Under ART

Background Tissue-resident macrophages (TRMs) may serve as HIV reservoirs during antiretroviral therapy (ART). Unlike peripheral CD4+ T cells, TRMs are harder to access and typically require autopsy/biopsy. The term placenta provides a unique model for TRM studies because it is accessible at birth and enriched in maternal decidual macrophages (dMs) and fetal Hofbauer cells (HBCs).…

655 – Pitavastatin Effects on Lipids in Relation to MACE: A REPRIEVE Secondary Analysis

Background The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) demonstrated a 36% reduction in major adverse cardiovascular events (MACE) with pitavastatin among people with HIV (PWH). Little is known about the relationship between lipid-lowering and MACE in this population. We evaluated pitavastatin effects on lipids and examined mediation of pitavastatin effects on MACE…

924 – Prevalence and Incidence of Advanced HIV Disease in AFRICOS Participants With Viral Nonsuppression

Background Advanced HIV disease (AHD) is a risk for people living with HIV (PLHIV) experiencing viral non-suppression (VNS). We determined AHD prevalence at VNS and identified factors associated with incident AHD after VNS amongst PLHIV enrolled in The African Cohort Study (AFRICOS), a multi-country longitudinal study. Methods We analyzed data from patient visits conducted every…

662 – Association of Metabolic and Inflammatory Indices With Subclinical Carotid Atherosclerosis in PLWH

Background People living with HIV (PWH) face an elevated risk of cardiovascular disease (CVD), partly attributable to chronic inflammation and altered body composition. Although Obesity-, lipid-, metabolic-, and inflammatory-related indices (OIMIs) have been linked to subclinical atherosclerosis (SCA) in the general population, their comprehensive evaluation in PWH remains limited. This study aimed to systematically assess…